Cargando…

Shufeng Jiedu capsule for acute exacerbation of chronic obstructive pulmonary disease: a protocol of multicentre, randomised, double-blind, placebo-controlled trial

INTRODUCTION: Chronic obstructive pulmonary disease (COPD) represents one of the leading causes of death worldwide. Published clinical trials suggest that the Chinese patent herbal medicine Shufeng Jiedu capsule (SFJD) is safe and may be effective for treating acute exacerbations of COPD (AECOPD). H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Ruyu, Fei, Yutong, Zhang, Lishan, Jie, Zhijun, Fan, Xiaoyun, Dai, Mengyuan, Moore, Michael, Willcox, Merlin, Hu, Xiaoyang, Francis, Nick, Liang, Changhao, Fei, Guanghe, Liu, Jianping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Respiratory Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546128/ https://www.ncbi.nlm.nih.gov/pubmed/37775286 http://dx.doi.org/10.1136/bmjopen-2022-070864

Ejemplares similares

Shufeng Jiedu capsules for treating acute exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Xia, Ru-yu, et al.
Publicado: (2020)

Study on basic and clinical application of Shufeng Jiedu Capsule in treating respiratory tract infection
por: Han, Yanqi, et al.
Publicado: (2023)

Chinese Patent Medicine Shufeng Jiedu Capsules as an Adjuvant Therapy for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools
por: Xiong, Haijun, et al.
Publicado: (2020)

The add-on effect of Shufeng Jiedu capsule for treating COVID-19: A systematic review and meta-analysis
por: Sheng, Xiaodi, et al.
Publicado: (2022)

Efficacy and safety of Shufeng Jiedu Capsule in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis
por: Ren, Huijun, et al.
Publicado: (2021)

Efficacy and safety of Shufeng Jiedu capsule in the treatment of COVID-19: A protocol for systematic review and meta analysis
por: Ma, Li, et al.
Publicado: (2020)

Chinese patent herbal medicine (Shufeng Jiedu capsule) for acute upper respiratory tract infections: A systematic review and meta-analysis
por: Zhang, Ying-ying, et al.
Publicado: (2021)

Analysis of the active components and mechanism of Shufeng Jiedu capsule against COVID-19 based on network pharmacology and molecular docking
por: Simayi, Jimilihan, et al.
Publicado: (2022)

Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology
por: Chen, Xiao, et al.
Publicado: (2020)

Efficacy and safety of Shufeng Jiedu capsule for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta-analysis
por: Li, Runmin, et al.
Publicado: (2020)

Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB to alleviate LPS-induced ALI
por: Cai, Junnan, et al.
Publicado: (2022)

Systematic analyses on the potential immune and anti-inflammatory mechanisms of Shufeng Jiedu Capsule against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-caused pneumonia
por: Tao, Zhengang, et al.
Publicado: (2020)

Vitamin D in the prevention of exacerbations of asthma in preschoolers (DIVA): protocol for a multicentre randomised placebo-controlled triple-blind trial
por: Jensen, Megan E, et al.
Publicado: (2019)

Nocturnal emergency department visits, duration of symptoms and risk of hospitalisation among adults with asthma exacerbations: a multicentre observational study
por: Yasuda, Hideto, et al.
Publicado: (2016)

Individualised risk prediction model for exacerbations in patients with severe asthma: protocol for a multicentre real-world risk modelling study
por: Lee, Tae Yoon, et al.
Publicado: (2023)

Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying bronchodilators in preventing exacerbations of bronchiectasis
por: Morton, Miranda, et al.
Publicado: (2023)

How far do we still need to go? A survey on knowledge, attitudes, practice related to antimicrobial stewardship regulations among Chinese doctors in 2012 and 2016
por: Xia, Ruyu, et al.
Publicado: (2019)

Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study
por: XIA, Lu, et al.
Publicado: (2021)

Effect of PIFR-based optimised inhalation therapy in patients recovering from acute exacerbation of chronic obstructive pulmonary disease: protocol of a prospective, multicentre, superiority, randomised controlled trial
por: Hua, Jianlan, et al.
Publicado: (2020)

Multicentre double-blind randomised controlled trial of systematic corticosteroid therapy in patients with acute exacerbations of chronic obstructive pulmonary disease admitted to hospital with higher eosinophil levels: the ECHO protocol
por: Liang, Lirong, et al.
Publicado: (2023)

The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study
por: Schmidt, Sigrun Alba Johannesdottir, et al.
Publicado: (2014)

Renoprotective effects of Gushen Jiedu capsule on diabetic nephropathy in rats
por: Zhang, Lei, et al.
Publicado: (2020)

Behaviour-change intervention in a multicentre, randomised, placebo-controlled COPD study: methodological considerations and implementation
por: Bourbeau, Jean, et al.
Publicado: (2016)

K(V)1/D‐type potassium channels inhibit the excitability of bronchopulmonary vagal afferent nerves
por: Sun, Hui, et al.
Publicado: (2022)

Relationship between heart failure and the risk of acute exacerbation of COPD
por: Axson, Eleanor L, et al.
Publicado: (2021)

Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations
por: O'Reilly, Philip J, et al.
Publicado: (2013)

Systematic review and meta-analysis of prognostic factors of acute exacerbation of idiopathic pulmonary fibrosis
por: Kamiya, Hiroyuki, et al.
Publicado: (2020)

Acute Exacerbation and Respiratory InfectionS in COPD (AERIS): protocol for a prospective, observational cohort study
por: Bourne, Simon, et al.
Publicado: (2014)

A cohort study of mortality predictors in patients with acute exacerbation of chronic fibrosing interstitial pneumonia
por: Usui, Yutaka, et al.
Publicado: (2013)

A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD
por: Wilkinson, Tom M A, et al.
Publicado: (2017)

Prophylactic epinephrine for the prevention of transbronchial lung biopsy-related bleeding in lung transplant recipients (PROPHET) study: a protocol for a multicentre randomised, double-blind, placebo-controlled trial
por: Kalchiem-Dekel, Or, et al.
Publicado: (2019)

Phase II study of tight glycaemic control in COPD patients with exacerbations admitted to the acute medical unit
por: Archer, John R H, et al.
Publicado: (2011)

Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study
por: Hozumi, Hironao, et al.
Publicado: (2013)

Prognostic factors for acute exacerbation of idiopathic pulmonary fibrosis: protocol for a systematic review and meta-analysis
por: Kamiya, Hiroyuki, et al.
Publicado: (2019)

Protocol for establishing a core outcome set for evaluation in studies of pulmonary exacerbations in people with cystic fibrosis
por: McLeod, Charlie, et al.
Publicado: (2022)

Prognosis of acute exacerbation in idiopathic pulmonary fibrosis with pulmonary emphysema: a retrospective cohort study in Japan
por: Horio, Yukihiro, et al.
Publicado: (2022)

Idiopathic Pulmonary Fibrosis Registry China study (PORTRAY): protocol for a prospective, multicentre registry study
por: Xie, Bingbing, et al.
Publicado: (2020)

KMBARC registry: protocol for a multicentre observational cohort study on non-cystic fibrosis bronchiectasis in Korea
por: Lee, Hyun, et al.
Publicado: (2020)

Stratified assessment of the role of inhaled hypertonic saline in reducing cystic fibrosis pulmonary exacerbations: a retrospective analysis
por: Dmello, Dayton, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ubojeds33d4233kbgnpeps58o9